Search company, investor...

Founded Year



Unattributed - II | Alive

Total Raised


Last Raised

$15M | 2 yrs ago

About TheraPanacea

TheraPanacea is a medical technology company that focuses on the healthcare sector, specifically in the field of cancer care. The company offers AI-based software solutions for more efficient and precise cancer treatment planning and delivery, including adaptive radiotherapy and automatic delineation. TheraPanacea primarily serves the healthcare industry, with a particular emphasis on cancer centers and pharmaceutical companies. It was founded in 2017 and is based in Paris, France.

Headquarters Location

29 Rue du Faubourg Saint-Jacques

Paris, 75014,




Expert Collections containing TheraPanacea

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

TheraPanacea is included in 3 Expert Collections, including Artificial Intelligence.


Artificial Intelligence

11,383 items

Companies developing artificial intelligence solutions, including cross-industry applications, industry-specific products, and AI infrastructure solutions.


Digital Health

10,804 items

The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.


Oncology Tech

457 items

This collection includes companies applying technology to cancer care, diagnosis, and treatment. Examples include vendors offering cancer detection and diagnosis, oncology clinical decision support, real-world data, and AI oncology drug discovery.

TheraPanacea Patents

TheraPanacea has filed 1 patent.

The 3 most popular patent topics include:

  • classification algorithms
  • computer graphic artifacts
  • computer graphic techniques
patents chart

Application Date

Grant Date


Related Topics



Image processing, Computer graphic techniques, Machine learning, Classification algorithms, Computer graphic artifacts


Application Date


Grant Date


Related Topics

Image processing, Computer graphic techniques, Machine learning, Classification algorithms, Computer graphic artifacts



Latest TheraPanacea News

Biogen puts $15m into digital health alliance with TheraPanacea

Dec 15, 2021

December 15, 2021 Biogen has made a $15 million investment in digital health company TheraPanacea, which will go towards a project to find digital health tools aimed at neurological diseases. There’s another $41 million in possible future payments if the partnership progresses as planned, said Biogen, which is getting exclusive rights to TheraPancea’s machine learning and artificial intelligence platforms in neuroscience. The aim of the project is to develop tools that will “improve patient care, accelerate drug development, and further the understanding of the underlying pathologies of neurological diseases,” said the two partners. Paris, France-based TheraPanacea has already started to make waves in the digital health arena with its use of ART-Plan AI software to improve radiotherapy of cancer, which is being used in the clinical workflow of more than 40 leading European centres to improve efficiency and standardise treatment. The alliance with Biogen will focus on using ML and AI to interpret medical imaging and other clinical data sources to try to improve understanding of neurological diseases, and potentially to allow personalised and earlier treatment and improved clinical trials. According to Biogen, the project could result in shorter development times for new medicines, lower costs, and increase chances of success, alongside the hope of improved clinical outcomes for patients. TheraPanacea meanwhile said the cash injection will be invested in expanding its existing operations and workforce in Europe. “We believe that neuroscience is at an inflection point for innovation and breakthrough,”  said Martin Dubuc, head of Biogen Digital Health. “Advancements in technology may increase our ability to understand disease, target treatments, and manage risk,” he added. Biogen is a specialist in neurosciences and hit the headlines earlier this year when it won approval in the US for Aduhelm (aducanumab), the first drug for Alzheimer’s that is intended to address a pathology that underlies the disease. Its development partner for the drug, Japan’s Eisai, is also exploring the use of digital health tools and in October started a five-year clinical trial of a AI and augmented reality system developed by Altoida that aims to diagnose cognitive impairment earlier. Don't miss your daily pharmaphorum news.

TheraPanacea Frequently Asked Questions (FAQ)

  • When was TheraPanacea founded?

    TheraPanacea was founded in 2017.

  • Where is TheraPanacea's headquarters?

    TheraPanacea's headquarters is located at 29 Rue du Faubourg Saint-Jacques, Paris.

  • What is TheraPanacea's latest funding round?

    TheraPanacea's latest funding round is Unattributed - II.

  • How much did TheraPanacea raise?

    TheraPanacea raised a total of $19.15M.

  • Who are the investors of TheraPanacea?

    Investors of TheraPanacea include Biogen, EIT Health Bridgehead, French Healthcare NEXT Program, EIT Health, EDF Pulse Awards and 4 more.

  • Who are TheraPanacea's competitors?

    Competitors of TheraPanacea include Synaptiq and 1 more.


Compare TheraPanacea to Competitors

MVision AI Logo
MVision AI

MVision AI develops automatic segmentation and contouring software. The software integrates with hospital systems to provide contours of various critical structures. The company was founded in 2017 and is based in Helsinki, Finland.

Manteia Logo

Manteia is a company that focuses on adaptive radiotherapy treatment, operating within the healthcare and technology sectors. The company offers intelligent medical image processing solutions for radiation therapy, adaptive radiotherapy treatment planning systems, a radiotherapy AI model training platform, and an online adaptive plan QA system. These services primarily cater to the healthcare industry, specifically cancer centers. It was founded in 2017 and is based in Xiamen, Fujian.

Limbus AI Logo
Limbus AI

Limbus AI is a company that specializes in the healthcare technology sector, with a focus on radiation therapy. The company offers a product that uses artificial intelligence to automatically contour for radiation therapy, providing clinical grade contours backed by comprehensive research. This product is designed to be installed on existing computers, ensuring patient data remains local and secure. The company primarily serves the healthcare industry, particularly those involved in radiation therapy. It was founded in 2018 and is based in Regina, Saskatchewan.

Mirada Medical Logo
Mirada Medical

Mirada Medical develops medical imaging software applications. It provides simple and accessible solutions to complex image analysis problems in the diagnosis and treatment of cancer and other diseases. Its products improve consistency and productivity while enabling clinicians to deliver more personalized care. It was founded in 2000 and is based in Oxford, United Kingdom.

Synaptiq Logo

Synaptiq focuses on leveraging artificial intelligence (AI) in the healthcare sector, specifically in the field of radiotherapy. The company's main product is a revolutionary software that uses AI to distinguish between cancerous tumors and organs at risk, significantly reducing the time required for contouring in radiotherapy. Synaptiq primarily serves the healthcare industry, with a particular emphasis on cancer treatment centers and radiation oncologists. It was founded in 2020 and is based in Cluj-Napoca, Romania.

Varian Medical Systems Logo
Varian Medical Systems

Varian Medical Systems (NYSE: VAR) manufactures medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers, and medical oncology practices. Varian is a supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications, and X-ray imaging products for cargo screening and industrial inspection.


CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.